DJIA 16,596.86 197.19 1.20%
NASDAQ 4,410.06 93.98 2.18%
S&P 500 1,939.63 35.62 1.87%
market minute promo

140.45 -1.54 (-1.08%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SLXP $140.45 -1.08%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $142.93
Previous Close $141.99
Daily Range $138.86 - $143.51
52-Week Range $70.64 - $172.98
Market Cap $8.9B
P/E Ratio 165.10
Dividend (Yield) $0.00 (0.0%)
Volume 853,137
Average Daily Volume 2,475,393
Current FY EPS $0.97

Sector

Healthcare

Industry

Drugs

Salix Pharmaceuticals, Ltd. (SLXP) Description

A pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract. Website: http://www.salix.com/

News & Commentary

Actavis plc and Valeant Pharmaceuticals Inc. Battle for Allergan Inc.: Who Wins?

Valeant Pharmaceuticals upped its bid offer for Botox maker Allergan by $15 a share yesterday. Actavis reportedly responded with an even richer offer. Will activist investor Bill Ackman get his way or will six months of work go down the drain?

Will Activis Win Competition For Allergan's Affection?

Sector Update: Health Care Stock Retreat; Shire Tumbles After Abbvie Reconsiders $55 Bln Inversion D

Sector Update: Health Care Stock Retreat; Shire Tumbles After Abbvie Reconsiders $55 Bln Inversion Deal

Sector Update: Health Care

These companies love seeing a stronger dollar

Allergan Raises Outlook amidst Valeant Takeover Attempts - Analyst Blog

Bill Ackman and Valeant Could Sweeten Allergan Deal By $15 A Share

Salix's Rectal Foam Uceris Receives Final FDA Approval - Analyst Blog

Progenics Gets $40M Milestone on FDA Approval of Relistor - Analyst Blog

Actavis Finds Rx To Grow On Busy Drugmaker M&A Scene

See More SLXP News...

SLXP's Top Competitors

SLXP $140.45 (-1.08%)
Current stock: SLXP
JNJ $100.25 (1.06%)
Current stock: JNJ
NVS $88.54 (0.73%)
Current stock: NVS
RHHBY $36.38 (1.46%)
Current stock: RHHBY